A win today would snap the DJI's three-day losing streakThe Dow Jones Industrial Average (DJI) briefly fell into negative territory shortly after the open, pressured by another drop for blue chip Boeing (BA). However, the Dow has since swung to a triple-digit lead -- on track to snap its three-day losing streak -- boosted by a round of relatively positive economic data and a big analyst-induced po...Read More

Fed funds futures are pricing in an all-but-certain March rate hikeThe marquee event for traders next week is the Federal Open Market Committee's (FOMC) two-day policy setting meeting, with fed funds futures pricing in a nearly 89% chance of a Fed rate hike. Fed Chair Jerome Powell will also be in focus, with the new central bank head participating in his first press conference following the polic...Read More

Leerink isn't worried about a clinical hold on SLDB's DMD drugShares of Solid Biosciences Inc (NASDAQ:SLDB) began trading publicly back on Jan. 26, opening at $25.50, well above their initial public offering (IPO) price of $16. And while SLDB stock went on to hit a record high of $33.74 on March 2, it's plunged 62.9% this morning to trade at $9.74 -- earlier hitting an annual low of $9.52 -- after...Read More

The $80 level has been a key price point for RGLD stockRaymond James believes it's time to buy precious metals stock Royal Gold, Inc (NASDAQ:RGLD). The brokerage firm upgraded the shares to "outperform" from "market perform," and increased its price target to $98 from $90 -- territory not charted since October 2012. A number of factors were listed in the bullish note, including the company's stron...Read More

More analysts could board the bullish bandwagon, tooAkamai Technologies, Inc. (NASDAQ:AKAM) stock has been on a tear lately, and shows no signs of stopping. This morning, KeyBanc upgraded the cloud services specialist to "sector weight" from "underweight." The analyst in coverage waxed optimistic on the company's margin expansion abilities and backing by activist investor Elliott Management. As a...Read More

The NDX is signaling a negative open, thoughU.S. stock futures are trading mixed this morning. Trade war fears are likely to stay front and center on Wall Street, with Larry Kudlow -- the White House chief economic adviser appointee -- saying "China needs a comeuppance on trade." It's also setting up to be another big day for economic data, as traders this morning already respond to a modest drop...Read More

Boeing stock was the biggest blue-chip loser Stocksstartedoff strong, as traders weighed mixed data oninflation and retail sales. However, escalating concerns of a trade war with China ultimately sent the Dow down triple digits for the third straight day. Boeing (BA) was the biggest loser on the blue-chip index, amid fears the company could be targeted for tariff retaliation from Beijing. The S&P...Read More

Shares of RKDA and SILC are having volatile sessionsAn extended pullback in Boeing shares is again dragging the Dow lower. Among individual names making notable moves are agricultural biotech Arcadia Biosciences Inc (NASDAQ:RKDA), credit services provider Equifax Inc. (NYSE:EFX), and cloud stock Silicom Ltd (NASDAQ:SILC). Here's a quick look at what's driving shares of RKDA, EFX, and SILC. RKDA S...Read More

Escalating concerns about a trade war with China are weighing on industrial stocks, and have the Dow lower in afternoon trading. However, while many traders fear Beijing could single out Boeing (BA), in particular, for retaliation, Apple Inc. (NASDAQ:AAPL) and several of its suppliers could also take a hit. According to data from Goldman Sachs, Apple suppliers Skyworks Solutions Inc (NASDAQ:SWKS)...Read More

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) stock is trading up 5.4% at $16.95, as the shares try to recover from last month's earnings bear gap. Boosting VRX stock this morning is news the company's plaque psoriasis treatment, Siliq, has been approved in Canada. Valeant expects to begin marketing efforts in the country later this year.Also helping Valeant stock today are Securities and Exchange C...Read More

Broadcom Ltd (NASDAQ:AVGO) is slated to report fiscal first-quarter earnings after the market closes on Thursday, March 15. The chip name could use a win, after ending its hostile bid for Qualcomm (QCOM), which was blocked earlier this week by President Donald Trump -- citing national security concerns. Ahead of tomorrow's earnings report, AVGO options are pricing in an outsized move for Friday'...Read More

The Dow Jones Industrial Average (DJI) opened up the session up triple digits as traders digested a slightly stronger-than-forecast inflation update and a third straight monthly drop in retail sales ahead of next week's March Fed meeting. The Dow has since swung to a more than 200-point loss at last check, though, as fears of a potential trade war with China -- following rumors the White House co...Read More

Any investor who wants to rake in big profits only really needs to know one thing:The biggest fortunes in the world right now are being made in technology.Take the following example:Amazon is now the world's third largest retailer, just behind Wal-Mart and CVS...Airbnb now offers more rooms than Hilton, InterContinental and Marriott... and according to investors it's now the most valuable "hotel s...Read More

The shares of mobile payments concern Square Inc (NYSE:SQ) are exploring record highs again today, thanks to a high-profile endorsement. Sixty-percent of Square merchants surveyed by Instinet said they'd be willing to accept payment in the form of bitcoin, prompting Instinet analyst Dan Dolev to say, "Like Amazon in its early days, we believe that little of Square's future revenue streams are curr...Read More

Signet Jewelers Ltd. (NYSE:SIG) has a history of making volatile post-earnings swings, and today's action is no different. But despite the retailer being one of the best stocks to own on the S&P 500 Index (SPX) in March over the past decade, SIG shares have plummeted 16% out of the gate to $40.09, hitting a six-year low of $4.02 earlier, after the jewelry specialist reported earnings this morning....Read More

Nvidia Corporation (NASDAQ:NVDA) stock has been on a tear lately, and analysts are taking notice. This morning, RBC upped its price target on the chip stock to $285 from $280. While the covering analyst expects cryptocurrency tailwinds to slow, continued growth in spending on data centers and gaming should fuel demand for the company's chips. Still, NVDA stock is down 0.3% at $247 so far today....Read More

Dow Jones Industrial Average (DJI) futures are trading above fair value, as stocks try to recover from yesterday's politically driven pullback. Concerns surrounding trade and tariffs could linger today, however, after CNBC reported the White House is considering placing indefinite tariffs on China, on top of other restrictions. Traders are also considering another big round of economic data. Namel...Read More

We are 50 days into 2018, and already it has been a turbulent year for stocks. The S&P 500 Index (SPX) was up over 7% within the first month of trading, but quickly reversed and found itself down on the year by nearly 4%. It has bounced back strong in March, sitting at a year-to-date gain of about 4% -- which has been the norm since 2010. Performance-wise, the S&P 500 has been no match for the Nas...Read More

Stocks once again started the day off strong, thanks to encouraging inflation data, and initially shook off President Donald Trump's abrupt dismissal of Secretary of State Rex Tillerson. However, a drop in energy and tech stocks -- not to mention a steep analyst-induced plunge for General Electric shares -- ultimately sent the Dow down triple digits for the second straight day. Even theNasdaq fini...Read More

Pharmaceutical stocks went on a tear recently, with the iShares Nasdaq Biotechnology ETF (IBB) fresh off a seven-day winning streak -- its longest series of consecutive gains since March 2015. While the IBB is set to snap that streak today, a pair of high-flying biotech stocks could be ripe for more upside -- and their near-term options are a relative bargain right now: Vertex Pharmaceuticals Inc...Read More